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Purpose: The purpose of the study was to define the histological
origin of gonadoblastomas, allowing the identification of high-risk
patients.
Experimental Design: Sixty paraffin-embedded gonadectomy or
gonadal biopsy samples of 43 patients with gonadal dysgenesis were
selected from our archives. We studied the morphology and immu-
nohistochemical properties of the germ cells in 40 samples without
neoplastic transformation and compared these findings with the mor-
phological and immunohistochemical characteristics of 20 samples
containing gonadoblastoma/dysgerminoma.
Results: The overall incidence of germ cell tumors in our patient
series was 35%. In dysgenetic gonads without germ cell neoplasia,
besides the presence of areas with testicular and/or ovarian differ-
entiation, areas of undifferentiated gonadal tissue were identified in
13 of 40 samples (32.5%). A subpopulation of germ cells within these
undifferentiated areas stained positive for octamer binding transcrip-
tion factor (OCT)3/4, the stem cell factor receptor, placental-like al-
kaline phosphatase, and testis-specific protein-Y encoded. Gonado-
blastoma germ cells display identical staining results. Moreover, in
gonads containing gonadoblastoma, adjacent to this lesion, areas of
undifferentiated gonadal tissue with identical immunohistochemical
characteristics were identified in 10 of 20 samples (50%). No adjacent
tissue was available in five cases, whereas in the five remaining cases,
it consisted of streak tissue. In three cases, an accumulation of OCT3/
4-positive germ cells in the proximity of the malignant lesions was
found, suggesting clonal expansion and final organization into go-
nadoblastoma nests.
Conclusions: Based on these observations, we hypothesize that go-
nadoblastomas originate from surviving OCT3/4-positive germ cells
in areas of undifferentiated gonadal tissue within the dysgenetic
gonad. Supportive evidence was obtained that carcinoma in situ
arises in regions with testicular differentiation. (J Clin Endocrinol
Metab 91: 2404–2413, 2006)
GONADOBLASTOMA IS HISTOLOGICALLY definedas a tumor composed of two principal cell types: large
germ cells similar to those of seminoma, and small cells
resembling immature Sertoli and granulosa cells; elements
resembling Leydig or lutein-like cells may also be present (1).
This premalignant lesion of the dysgenetic gonad is the coun-
terpart of the more frequent carcinoma in situ (CIS) lesion,
which is found in well-differentiated testicular tissue (2).
Gonadal dysgenesis is defined as an incomplete or defective
formation of the gonads, resulting from a disturbed process
of migration of the germ cells and/or their correct organi-
zation in the fetal gonadal ridge. It is caused by structural or
numerical anomalies of the sex chromosomes or mutations
in one of the genes involved in the formation of the urogenital
ridge and sex determination of the bipotential gonad. Neo-
plastic transformation of germ cells in dysgenetic gonads (the
formation of gonadoblastoma and/or an invasive germ cell
tumor) occurs, according to literature data in 20–30% of cases
and is associated with the presence of (part of) the Y chro-
mosome in the patients’ karyotype (3, 4). It is usually diag-
nosed at a young age (3, 5, 6). Therefore, early gonadectomy,
often combined with gender reassignment and genital sur-
gery, is mostly advocated (3, 6, 7). This safe but radical
approach results definitely in infertility and lifelong depen-
dence on hormonal replacement therapy in all patients.
However, genital surgery and early gender assignment pro-
cedures have become controversial (8–11). Hormonal sub-
stitutes are sometimes considered as unphysiological, com-
pared with endogenous hormone production. Advances in
surgical techniques now allow rearing an individual born
with ambiguous genitals as a male, preferably with his go-
nads positioned into the scrotum (9, 12). The incidence of
malignancy in true hermaphroditism is estimated at 2–10%
(4, 13) and is thus considerably lower than in other diagnostic
groups. Interestingly, preservation of gonadal function has
been described mainly in this specific group (13, 14) but also
in some other patients with gonadal dysgenesis (15, 16).
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These observations led the French group of Josso and co-
workers (14) to propose a more conservative approach re-
garding gonadectomy in true hermaphroditism.
Dysgenetic gonads containing a germ cell tumor have been
examined in more detail in several patient series (5–7, 15, 17).
These combined data reveal that the gonad of origin is con-
sidered as a dysgenetic testis in 19.8% of cases and a streak
in 26.1%, and that it could not be determined in 54.1% of
cases. The impossibility to predict (e.g. from a gonadal bi-
opsy) which gonad is prone to neoplastic transformation
hampers the application of a more conservative approach
relative to gonadectomy on a wider scale.
To gain insight into the nature of the gonads in which
gonadoblastoma and invasive tumors may arise, we studied
the histological and immunohistochemical properties of 40
dysgenetic gonads, removed as a prophylactic measure and
in which no malignancy was detected on routine patholog-
ical examination, and compared them with the histological
and immunohistochemical characteristics of 20 gonads con-
taining gonadoblastoma and/or dysgerminoma lesions. Im-
munohistochemistry was performed with the antibodies oc-
tamer binding transcription factor (OCT) 3/4, c-KIT (the
stem cell factor receptor), and placental-like alkaline phos-
phatase (PLAP), which are normally expressed in primordial
germ cells/gonocytes and are well-established markers for
the diagnosis of CIS and gonadoblastoma (18–22). Further-
more, the expression of testis-specific protein-Y encoded
(TSPY), encoded by the TSPY gene and the main candidate
gene responsible for the development of gonadoblastoma
(19–21, 23, 24) and the human homolog of the mouse vasa
gene (VASA), a general marker for germ cells (20, 25), was
examined (Table 1). Sertoli/granulosa cells were examined
for their expression of anti-Müllerian hormone (AMH).
Patients and Methods
Tissue samples
Forty-five patients with gonadal dysgenesis were retrieved from our
archives. Samples of 20 dysgenetic gonads containing gonadoblastoma
and/or dysgerminoma in 16 different patients and 40 dysgenetic gonads
without apparent malignancy in 27 different patients were selected;
three samples in two patients were excluded due to bad preservation of
material. Patient and tissue characteristics are summarized in Table 2.
Two fetal samples (Table 2, patients 1 and 2) obtained after induced
abortion were included. Patient 5 underwent a bilateral gonadal biopsy
at 4 months and a right gonadectomy 2 months later. A left gonadectomy
was performed at 14 yr. Patient 26 underwent a right gonadectomy at
8 yr and a left gonadectomy at 25 yr.
Use of tissues for scientific reasons was approved by an institutional
review board. The samples were used according to the Code for Proper
Secondary Use of Human Tissue in The Netherlands, as developed by
the Dutch Federation of Medical Scientific Societies (version 2002) (26).
Samples originating from collaborating centers in Belgium, Poland, and
Indonesia were treated in accordance with the above mentioned as well
as local medical ethical guidelines.
Immunohistochemical staining
Tissue material was fixed in 10% formalin or Bouin’s fixative, ac-
cording to local fixation procedures. Slices of 3–5 m thickness were
prepared.
The antibodies used for immunohistochemistry and a schematic rep-
resentation of the applied protocols are represented in Table 1. Slides
were incubated with the primary antibodies at appropriate dilutions,
staining was performed using 3,3-diaminobenzidine-tetrahydrochlo-
ride dehydrate (DAB)/H2O2 or New Fuchsin (Fluka Chemica, Stein-
heim, Germany)/Naphtol ASMX (Sigma Aldrich, Zwijndrecht, The
Netherlands) phosphate and counterstaining with hematoxylin. As pos-
itive controls, a normal adult male gonad for VASA, a seminoma sample
for PLAP, c-KIT, TSPY and OCT3/4 and a male fetus, 8 wk gestational
age (GA) for AMH were included.
Double-staining experiments were performed using the same detec-
tion methods but with different substrates: Fast Blue/Naphtol ASMX
phosphate (F3378 and N500; Sigma, Steinheim, Germany) for a blue
TABLE 1. Schematic representation of origin and protocols used for the different antibodies
Origin Code Dilution Pretreatment HIAR Incubation Secondaryantibody
AB
complex Chromogen
Primary antibody
VASA Kindly provided by
Dr. D. H. Castrillona
1:1000 No Yes Overnight, 4 C SWAR-bio ABC-AP New fuchsine
PLAP Cell Marque, Hot
Springs, AR
CMC203 1:200 No Yes Overnight, 4 C RAM-bio ABC-AP New fuchsine
c-KIT Dako-Cytomation,
Glostrup, Denmark
A4502 1:500 No Yes Overnight, 4 C SWAR-bio ABC-AP New fuchsine
TSPY Kindly provided
by Prof. C. Laub
1:3000 No No Overnight, 4 C SWAR-bio ABC-AP New fuchsine
OCT3/4 Santa Cruz
Biotechnology,
Santa Cruz, CA
SC8629 and
SC5279
1:1000 H2O2 for 5 
biotin blocking
Yes 2 h, RT HAG-bio ABC-HRP DAB
AMH Kindly provided by
Prof. A. Themmenc
1:200 H2O2 for 5 
biotin blocking
Yes Overnight, 4 C RAM-bio ABC-HRP DAB
Secondary antibody
SWAR Dako-Cytomation 1:200
RAM Dako-Cytomation 1:200
HAG Vector Laboratories,
Burlingame, CA
1:200
HIAR, Heat-induced antigen retrieval (40); SWAR, swine antirabbit antibody; RAM, rabbit antimouse antibody; HAG, horse antigoat
antibody; bio, biotin labeled; AB complex, streptavidin-biotin complex; ABC-AP, streptavidin-biotin-alkaline phosphatase complex; ABC-HRP,
streptavidin-biotin-horseradish peroxidase complex; RT, room temperature.
a Department of Pathology, University of Texas, Southwestern Medical Center, Dallas, Texas.
b Department of Medicine, Veterans Affairs Medical Center, University of California, San Francisco, San Francisco, California.
c Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
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TABLE 2. Overview of patient and tissue characteristics
Patient Age Karyotype Phenotype
Histology
Remarks
T O UGT S Tumor
1 17 wk 45,X/46,XY Male     
2 19 wk 45,X (7/20) /46,XY (13/20) Male     
3l 1 month 46,XX Female     
3r 1 month     
4l 4 months 46,XX Female     Calcified GB
4r 4 months     GB
5r 4 months 46,XY Female      r Biopsy
5l 4 months      l Biopsy
5r 6 months      r Gonadectomy
5l 14 yr     GBDG l Gonadectomy
6l 6 months 45,X (22/50) /46,X der(Y) (28/50) Male     
6r 6 months      Biopsy
7l 6 months 45,X/46,X iso(Y) Male     
8 11 months 46,Xyder(9) t(7;9) (q13.2;p24.2) Male     
9l 1 yr 45,X/46,XY Female     GB
9r 1 yr     
10l 1 yr 46,XY Male     
11 1 yr 46,XX/46,XY Female     
12 1 yr 45,X (10/100) /46,XY (90/100) Male      Biopsy
13l 1 yr 45,X (12/50)/46,XY (38/50) Male     
14l 2 yr 45,X (53/74) /46,Xi(Yp) (21/74) Male     
15 2 yr 46,XY Female     
16l 3 yr 45,X/46,XY Female     
17r 3 yr 46,XX (30/100) /46,XY (70/100) Male     
18l 4 yr 45,X, inv(5) (q22q33.2); 46,X i(Y9),
inv(5) (q22q33.2)
Female     
18r     
19l 4 yr 46,XX Male, later     
19r Female      T: no germ cells
20 4 yr 45,X (11/25) /46,XY (14/25) Male     
21 5 yr 46,XY Male     
22l 6 yr 46,XX Male      T: no germ cells
23 7 yr 46,XY Female     GB
24r 7 yr 46,XX/46,XY Male     
24l     
25r 7 yr 45,X/46,XY Male      Biopsy, T: no germ cells
25l 8 yr      Biopsy, T: no germ cells
26r 8 yr 45,X/46,XY Male     
26l 25 yr     GB
27r 9 yr 46,XY Female     Calcified GB
 MT  IT
28r 10 yr 45,X (7/12)/46,XY (5/12) - second
count: 45,X (40/40)
Male     
29r 14 yr 46,XY Female     GB
29l 14 yr     
30r 14 yr 46,XX Female     
31r 14 yr 45,X/46,XY Female     
31l     
32r 16 yr 46,XY Female     GB
32l     GB
33 16 yr 46,XY Female     GB
34l 17 yr 45,X/46,XY Female     Calcified GB
35r 17 yr 45,X (12/30) /46,XY (18/30) Female     
36l 17 yr 45,X (5/50)/46,XY (45/50) Female     
37r 18 yr 46,XY Female     GBDG
37l     GB
38 18 yr 46,XY Female     GB
39r 19 yr 46,XY Female     GBDG
39l     GB
40 19 yr ? Female     
41 20 yr 45,X/46,XY Male     GBDG
42l 21 yr 46,XY Male     GBCIS
43 25 yr 46,XY Male     DG
Laterality of the gonad and karyotype are indicated if known. Age, Age at gonadectomy or biopsy; l, left; r, right; GB, gonadoblastoma; DG,
dysgerminoma; MT, mature teratoma; IT, immature teratoma; T, testis; O, ovary; S, streak; wk, weeks GA.
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staining and 3-amino-9-ethyl-carbazole (A.5754 and D4254, Sigma)/
H2O2 for a red staining, without counterstaining. To reduce background
signal, endogenous peroxidase activity and endogenous biotin were
blocked using 3% H2O2 (5 min) and a blocking kit for endogenous biotin
(Vector Laboratories, Burlingame CA). For a correct interpretation of
histology, hematoxylin-eosin (HE) staining was performed on parallel
slides.
Interpretation of results
General morphology and interpretation of the staining results were
assessed by two observers with experience in germ cell pathology (M.C.
and J.W.O.). Part of the results obtained in five gonadoblastoma samples
were reported previously (21).
Statistical analysis
Results were analyzed using the SPSS (SPSS 11.0 for Windows; SPSS
Inc., Chicago, IL) statistical program (Fisher exact test for 2  2 tables).
Results
Morphology and staining results in dysgenetic gonads
without neoplastic transformation
Four gonadal differentiation patterns were recognized in
various combinations (Tables 2 and 3 and Fig. 1).
First, tissue containing seminiferous tubules was encoun-
tered in 24 of 40 gonads (60%) and was considered as a
testicular differentiation pattern. The tubules often displayed
FIG. 1. Differentiation patterns encountered in dysgenetic
gonads without neoplastic transformation: A, Patient 30r.
Dysgenetic testicular tissue, containing germ cells (arrow-
heads). HE staining, 400. B, Patient 18r. Testicular tis-
sue. OCT3/4-positive cells are located in the center of the
tubule but are also found on the basal lamina. OCT3/4
staining, 200. C, Same patient. A subpopulation of germ
cells (recognized by the VASA staining) expresses OCT3/4.
OCT3/4-positive cells are located in the center of the tubule
(arrows) but are also found on the basal lamina (arrow-
heads). OCT3/4 (blue)-VASA (red) double staining, 400. D,
Patient 19r. Testicular (left part) and ovarian (right part)
differentiation; the testicular tissue is devoid of germ cells;
ova are enclosed in primordial and primary follicles. HE
staining, 200. E, Patient 14l. Undifferentiated gonadal
tissue. Germ cells align in clusters together with Sertoli/
granulosa cells or lay isolated in fibrous stroma. HE stain-
ing, 200. F, Same patient. A subpopulation of germ cells
within the UGT area expresses OCT3/4. OCT3/4 (blue)-
VASA (red) double staining, 200. G, Patient 13l. Streak.
Remnants of cords that have lost their germ cells and have
undergone a fibromatous reaction are recognizable. HE
staining, 200.
TABLE 3. Summary of staining results in the encountered
gonadal differentiation patterns and in gonadoblastoma
(GB)/dysgerminoma (DG)
Testis UGT Ovary Streak GB DG
OCT3/4      
PLAP      
c-KIT      
TSPY      /
VASA      /
, Positive expression; , no expression; , abundant expres-
sion; /, expression may be present or absent.
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abnormalities such as a thin basal lamina, shape irregularity,
increased intertubular spaces, and branching structures, re-
flecting their dysgenetic nature (Fig. 1A). Germ cells were
found in 20 of 24 samples (83%) and were easily recognized
by positive staining for VASA and TSPY. The TSPY staining
was consistently very intense, compared with normal adult
and age-matched controls as well as normal fetal testicular
samples (our personal observations). Staining of germ cells
for OCT3/4, c-KIT, and PLAP was performed in 18 of 24
samples; in the remaining six, it could not be performed due
to limited material. A subpopulation of germ cells stained
positive for the three markers in 14 of 18 samples (78%). In
all cases, positive cells were found centrally in the tubule,
pointing at a delay in maturation, but seven of 14 patients
(50%) also displayed positive germ cells on the basal lamina
(Fig. 1B). OCT3/4-VASA double-staining experiments con-
firmed these findings. In general, OCT3/4 expression was
lost as cells became positive for VASA, yet sometimes OCT3/
4-VASA coexpression was observed within a single cell (Fig.
1C). Regardless of their dysgenetic aspect, in all samples the
majority of the tubules displayed positive staining for AMH
in Sertoli cells.
Second, an ovarian differentiation pattern was defined as
gonadal tissue containing germ cells enclosed in primordial
and eventually growing follicles, comparable with the ova-
ries of female neonates (Fig. 1D). It was encountered in 10 of
40 gonads (25%). Ova homogeneously expressed VASA and
c-KIT, whereas OCT3/4-, PLAP-, or TSPY-positive ova were
never found. A unique situation was found in patient 3l:
follicles, containing VASA-positive and TSPY-negative ova,
were enclosed in seminiferous tubules, containing VASA-
positive, TSPY-positive spermatogonia (Fig. 2).
A third differentiation pattern, further referred to as un-
differentiated gonadal tissue (UGT), consisted of gonadal
tissue containing germ cells not enclosed in seminiferous
tubules or follicles but organized together with Sertoli/gran-
ulosa cells in cord-like structures or residing without appar-
ent organization in a background of fibrous stroma (Fig. 1E)
or a combination of these two. This pattern, although present
in 13 of 40 gonads (32.5%), was mostly not mentioned in the
original pathology reports, or alternatively, it was referred to
as a streak. Expression of markers in the germ cells within
UGT was similar to that found in testicular tissue. Germ cells
could easily be identified by their expression of VASA and
abundant expression of TSPY. Due to limited material,
OCT3/4, PLAP, and c-KIT staining could be performed in 11
of 13 samples. In nine of them (82%), a subpopulation of germ
cells within UGT stained positive for these three markers.
OCT3/4-VASA double staining confirmed these results (Fig.
1F). Sertoli/granulosa cells within UGT differed from their
apparently more differentiated counterparts in testicular tu-
bules: in most samples, AMH expression was totally absent,
although sporadic weakly positive Sertoli/granulosa cells
were found in two samples.
The fourth pattern, consisting of fibrous stroma devoid of
germ cells, was referred to as streak. It was found in 14 of 40
dysgenetic gonads (35%) in an age-related manner: four of 25
cases until 4 yr of age contained streak tissue (15%), whereas
it was found in 10 of 15 samples older than 4 yr (66%) (P 
0.002). Cord-like structures were often recognizable and
might represent UGT that has lost its germ cells and has
undergone a fibromatous involution (Fig. 1G). AMH expres-
sion was never observed in this tissue type.
Morphology and staining results in dysgenetic gonads
containing gonadoblastoma and/or dysgerminoma (Tables
2 and 3 and Fig. 3)
Typical gonadoblastoma nests were found in 16 of 20 sam-
ples, four of them also containing an invasive dysgerminoma
component and one combined with CIS. Three samples con-
sisted of large calcifications (the so-called burnt-out gonado-
blastoma), one of them in combination with mature and im-
mature teratoma. In one sample only dysgerminoma was
identified. Germ cells within gonadoblastoma stained positive
for OCT3/4, c-KIT, PLAP, and TSPY. TSPY was abundantly
expressed in every gonadoblastoma sample, but the expression
decreased in the invasive tumor components. The expression of
FIG. 2. A, Patient 3l. Ova in a primordial follicle (arrows)
are enclosed in seminiferous tubules containing spermato-
gonia (arrowhead). HE staining, 200. B, Same patient.
TSPY-negative ova (arrow) next to TSPY-positive sper-
matogonia (arrowhead), TSPY staining, 400. C, Same pa-
tient. Ova (arrow) and spermatogonia (arrowhead) both
express VASA. VASA staining, 200.
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OCT3/4, c-KIT, and PLAP was variable: in some gonadoblas-
toma samples, all the germ cells stained positive, whereas in
others, only a subpopulation of germ cells expressed these
markers; however, in the dysgerminoma samples, these mark-
ers were homogenously present. VASA expression within the
gonadoblastoma samples was variable: in 12 of 15 examined
samples, germ cells were positive; the remaining three samples
were negative for VASA.
Nonneoplastic gonadal tissue adjacent to the neoplastic
lesions was available in 15 of 20 samples (75%). The four dif-
ferentiation patterns described above were encountered: a
streak was found in five of 15 cases (33%), one in combination
with ovarian tissue, and UGT was present in 10 of 15 cases
(67%), one in combination with testicular tissue (Fig. 3, A–C).
Again, in UGT, germ cells stained positive for TSPY with a
remarkably strong intensity. In all samples containing UGT,
OCT3/4-, c-KIT-, and PLAP-positive germ cells were found
(Fig. 3D). In patients 23 and 39 (bilaterally), in the proximity of
the malignant lesions, an accumulation of OCT 3/4-positive
germ cells was found, suggesting clonal expansion and final
organization into gonadoblastoma nests (Fig. 3E).
These findings were confirmed in the OCT3/4-TSPY dou-
ble-staining results (Fig. 3, F and G).
Discussion
The overall incidence of germ cell tumors in 45 patients
with gonadal dysgenesis retrieved from our database was
35% (16 of 45 patients), with four bilateral cases. Invasive
germ cell tumors were found in six of 45 patients (13%).
We studied the histological and immunohistochemical
characteristics in dysgenetic gonads that have (not yet) un-
dergone neoplastic transformation and compared these find-
ings with the properties of the gonadal tissue adjacent to and
within gonadoblastoma samples. Given the rarity of the syn-
drome, a relatively large patient series could be collected.
However, due to limited material, some experiments were
performed in selected samples.
FIG. 3. A, Patient 37r. UGT with isolated germ cells (ar-
rows) adjacent to gonadoblastoma lesions (left). HE stain-
ing, 200. B, Patient 32r. Rectangle, Isolated germ cells in
the tissue adjacent to gonadoblastoma. HE staining, 100.
C, Same patient, enlargement of panel B. HE staining,
400. D, Same patient. Isolated OCT3/4-positive germ cells
in UGT adjacent to gonadoblastoma. OCT3/4 staining,
400. E, Patient 39l. Clonal expansion of OCT3/4-positive
cells within UGT in the close proximity of a gonadoblastoma
lesion. OCT3/4 staining, 50. F, Same patient. A subpopu-
lation of germ cells within UGT adjacent to gonadoblastoma
expresses OCT3/4 (red) and TSPY (blue). OCT3/4-TSPY
double staining, 200. G, Same patient. Most germ cells
within a gonadoblastoma lesion express OCT3/4 (red) and
TSPY (blue). OCT3/4-TSPY double staining, 200.
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In dysgenetic gonads, basically four patterns of gonadal
differentiation (with each pattern displaying a broad spec-
trum of abnormalities in morphology, number, and organi-
zation of the germ cells) were found: testicular and ovarian
tissue, streak, and UGT. The frequent finding of UGT was
unexpected because it had not been mentioned in the original
pathology reports, nor is it routinely described in literature,
although some histological descriptions might suggest the
presence of UGT (17, 27, 28). UGT clearly differed from the other
patterns: in contrast to streak tissue, it does contain germ cells,
but these are organized in neither seminiferous tubules nor
follicles. In contrast, these germ cells reside apparently ran-
domly distributed in a background of stromal cells or align in
clusters, in close contact with Sertoli/granulosa cells. Without
close observation and the use of specific markers, the germ cells
within UGT are easily overlooked, hence its frequent classifi-
cation as a streak. Alternatively, due to their presence in ovar-
ian-type stroma, and although they are not organized in folli-
cles, the germ cells are sometimes misinterpreted as residing in
ovarian tissue. However, their correct identification is of crucial
importance, as is illustrated in patient 5. In this girl, a bilateral
biopsy was performed at 4 months, followed by a gonadectomy
of the right testis because of its discordance with the sex of
rearing. The left gonad, which was considered as ovarian tissue,
was left in place. At the age of 14 yr, she developed a gonado-
blastoma, already having progressed to a dysgerminoma. A
reevaluation of the available biopsy material of the left gonad
unequivocally demonstrated germ cells and cord-like struc-
tures (Fig. 4, A–C). A similar case is found in the literature (6).
A significantly increased incidence of streak tissue was
found in patients older than 4 yr, compared with younger
patients (P  0.002). Cord-like structures were often recog-
nized, suggesting a loss of germ cells in UGT, analogous to
the germ cell loss that is observed in dysgenetic testicular or
ovarian tissue [e.g. the testicular tissue in hermaphrodites
(13) or the testes of patients with undervirilization syn-
dromes (19)]. This finding is in accordance with previous
reports (7).
The fate of the germ cells during normal human gonadal
development was described by Gondos (29) and is largely
analogous to the gonadal development and differentiation
process analyzed in detail in mice (30). At their arrival in the
genital ridge around 5 wk GA, the germ cells and pre-Sertoli/
granulosa cells lay intermingled without specific organiza-
tion in the undifferentiated gonad. The first sign of sexual
differentiation (the formation of primitive cords) coincides
with SRY expression, around wk 6 GA. In the absence of SRY,
no changes occur in the undifferentiated gonad until the 12th
week, when the germ cells enter meiosis. As stated above,
germ cells within UGT either lay randomly in fibrous stroma
or line up together with Sertoli/granulosa cells in cord-like
structures. It is conceivable that the first pattern represents
the undifferentiated state of the gonad, in which no accurate
SRY expression has taken place but in which under the in-
fluence of unknown (male) characteristics, meiosis and pro-
gression along the default pathway are inhibited. The second
pattern might represent early sex cords, blocked in their
progression toward seminiferous tubules (Fig. 5). The dif-
ferential staining results for AMH in testicular tubules and
cord-like structures support this hypothesis.
Germ cells were stained with the markers TSPY, OCT3/4,
c-KIT, PLAP, and VASA. TSPY expression was never en-
countered in ova enclosed in follicles. However, it was abun-
dantly expressed in germ cells within dysgenetic testes and
UGT, compared with the intensity of the TSPY staining in
fetal and age-matched normal gonads (19, 20, 31) (and our
personal observations), thereby suggesting an up-regulation
of TSPY when germ cells reside in an unfavorable environ-
ment. This is in line with previous observations in gonado-
blastoma (21). TSPY is thought to be related to the premeiotic
proliferation of spermatogonia, although its function is not
fully clarified (23). Evidence is growing that TSPY is the main
candidate for the hypothetical gene in the gonadoblastoma
region on the Y chromosome leading to the development of
gonadoblastoma (21, 24, 32). Abnormal TSPY expression has
also been related to the development of CIS in undervirilized
patients (19).
OCT3/4, c-KIT, and PLAP are well-established markers
FIG. 4. A, Patient 5l, biopsy performed at 4 months. Germ
cells are clearly recognizable in the biopsy sample of the left
gonad (arrows). HE staining, 400. B, Same patient. Germ
cells enclosed in cords are encountered in a PLAP staining
of the biopsy sample. PLAP staining, 200. C, Same pa-
tient, now 14 yr old. Gonadoblastoma of the left gonad
(lower part of the image); sporadic germ cells are still
present in the UGT adjacent to the gonadoblastoma lesion
(arrow). HE staining, 200.
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for the diagnosis of various germ cell tumors and are nor-
mally expressed during fetal gonadal development (20, 33).
Maturation delay of germ cells, which has been described in
intersex conditions and patients with chromosomal anom-
alies, is characterized by a prolonged expression of these
markers and is considered to be a risk factor for malignant
transformation (2, 19, 31, 34, 35). In the present series, these
three markers revealed similar staining patterns; however,
OCT3/4, resulting in a well-circumscribed and intense nu-
clear staining, was the most stable marker and was easiest for
interpretation. OCT3/4, a transcription factor regulating plu-
ripotency of embryonal stem cells and essential for the sur-
vival of migratory primordial germ cells (36), is consistently
expressed in specific germ cell tumors and might play a
pathogenetic role in their development (37, 38). In line with
previously reported results (33), OCT3/4 expression was
never found in ovarian follicles. In contrast, within testicular
tissue and UGT of dysgenetic gonads without gonadoblas-
toma and tissue adjacent to gonadoblastoma, a subpopula-
tion of germ cells expressed OCT3/4. Gonadoblastoma and
dysgerminoma also consistently expressed this marker (Figs.
1 and 3). In the proximity of a gonadoblastoma lesion, an
accumulation of OCT3/4-positive cells was observed, sug-
gesting clonal expansion within UGT toward gonadoblas-
toma formation (Fig. 3E). Previously we demonstrated that
OCT3/4-positive prespermatogonia located centrally in the
seminiferous tubule reflect a state of maturation delay,
whereas OCT3/4-positive cells on the basal lamina are prone
to malignant transformation (19). In the present study, the
latter pattern was encountered in seven samples. It is tempt-
ing to speculate that these patients were at high risk for
developing CIS, eventually progressing to invasiveness
within the dysgenetic testis if a gonadectomy had not been
performed.
Based on our results, a model for the development of
gonadoblastoma and CIS in the dysgenetic gonad containing
Y chromosome material (i.e. the TSPY gene) emerges: a dys-
genetic gonad may consist of different parts with various
degrees of differentiation (ovarian tissue, in which the germ
cells evolve along the default pathway of meiosis). These
germ cells have lost OCT3/4 expression and do not express
TSPY; therefore, they cannot give rise to a malignant germ
cell tumor. Testicular tissue, showing variable degrees of
dysgenesis, contains germ cells that abundantly express
TSPY, possibly in an attempt to survive and proliferate in an
unfavorable environment. Some of these germ cells maintain
FIG. 5. Model for the development of UGT, gonadoblastoma, and CIS within the dysgenetic gonad. Upper panel, In the developing embryo, germ
cells migrate from the yolk sac into the bipotential gonad and intermingle with pre-Sertoli/granulosa cells. Middle panel (from the right to the
left), In the male, SRY expression in the sixth week GA induces organization of pre-Sertoli cells and germ cells in primitive sex cords (SC). Under
the influence of other male sex-determining genes downstream of SRY, these sex cords differentiate into seminiferous tubules. Pathological
conditions can cause a block or delay in the normal germ cell development, thereby increasing the risk for formation of intratubular germ cell
neoplasia unclassified. Lower panel, In gonadal dysgenesis, inaccurate or absent SRY expression or a disturbed expression of other male-
determining genes prohibits sex cord formation or further differentiation of sex cords, whereas progression along the meiosis-default pathway
is also blocked (lower panel, right), resulting in the persistence of UGT. Surviving germ cells residing in UGT (including immature sex cords)
contain a high risk for the development of GB (lower panel, middle). GB, Gonadoblastoma.
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OCT3/4 expression, even after having reached the spermato-
gonial niche due to a block in their maturation. Over time,
most of these germ cells will die; however, some, possibly
due to abundant TSPY levels and prolonged OCT3/4 ex-
pression, will survive and proliferate, eventually leading to
clonal expansion and CIS formation. In UGT, a similar pro-
cess takes place, ending in a streak in case all the remaining
germ cells die or alternatively in the development of go-
nadoblastoma (Fig. 5). If the latter evolution takes place more
rapidly than the progression toward CIS, this would explain
the more frequent finding of gonadoblastoma rather than CIS
in dysgenetic gonads containing both UGT and testicular
tissue. Alternatively, it is conceivable that immature germ
cells, blocked in their maturation but residing in UGT, which
is their natural environment during early embryonic life,
have increased survival chances, compared with immature
germ cells residing in more differentiated testicular tissue.
Our findings are not disconcordant with the hypothesis that
gonadoblastomas originate from germ cells developing
along the female pathway but failing to complete the meiotic
prophase and organize in primordial follicles (39).
In conclusion, extrapolation to a clinical situation would
suggest that a gonadal biopsy revealing the presence of UGT
or testicular tissue with OCT3/4-positive cells on the basal
lamina contains a high risk for germ cell tumors and should
imperatively lead to gonadectomy. Ovarian tissue can safely
be left in place; testicular tissue displaying maturation delay
of germ cells can be left in situ, given that its localization
allows adequate follow-up. A streak is not functional, mak-
ing its preservation controversial. Evidently the decision
with regard to gonadectomy is not only based on a patho-
logical analysis of biopsy material but also must be inspired
by the combined interpretation of the patients’ karyotype,
internal genitalia, phenotype, gender, and psychological
well-being. The value, safety, and applicability of this model
should be thoroughly tested in large patient series and mul-
ticenter studies before it may contribute to a more conser-
vative approach regarding gonadectomy in selected patients
with gonadal dysgenesis.
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